Using symptom improvement patterns to predict remission in depressed outpatients treated with venlafaxine extended release (XR) or selective serotonin reuptake inhibitors (SSRI)

被引：0

作者：

Trivedi, MH ^{[1
]}

Grannemann, BD ^{[1
]}

Musgnung, J ^{[1
]}

Jiang, Q ^{[1
]}

Tummala, R ^{[1
]}

Thase, ME ^{[1
]}

机构：

[1] Univ Texas, SW Med Ctr, Dallas, TX USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2005年 / 30卷

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：S241 / S242

页数：2

共 8 条

[1] Employing symptom improvement patterns to predict remission in depressed outpatients treated with venlafaxine extended release (XR) or selective serotonin reuptake inhibitors
Trivedi, M.
Grannemann, B.
Musgnung, J.
Jiang, Q.
Tummala, R.
Thase, M.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S183 - S183
[2] Rates of complete remission of individual symptoms in depressed patients treated with venlafaxine, selective serotonin reuptake inhibitors, or placebo
Entsuah, R
Zhang, J
Fawcett, J
NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S100 - S100
[3] Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors
Rudolph, RL
ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 : 24 - 30
[4] Depression remission with venlafaxine XR or selective serotonin reuptake inhibitors in a primary care setting using treatment algorithms and length of treatment guidelines
Trivedi, MH
Benattia, I
Musgnung, J
Graepel, J
Gelenberg, A
NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S212 - S212
[5] Safety of Oxymorphone Extended Release in Depressed Patients Taking Selective Serotonin- or Serotonin-Norepinephrine Reuptake Inhibitors
Peniston, John H.
Potts, Susan
Hu, Xiaojun
Wieman, Matthew S.
AMERICAN JOURNAL ON ADDICTIONS, 2012, 21 (04): : 394 - 394
[6] Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?
Kertzman, Semion
Vainder, Michael
Reznik, Ilya
Gotzlav, Yossef
Weizman, Abraham
Kotler, Moshe
Iancu, Iulian
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (03) : 134 - 141
[7] Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder
Trivedi, MH
Wan, GJ
Mallick, R
Chen, JL
Casciano, R
Geissler, EC
Panish, JM
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (05) : 497 - 506
[8] Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: A meta-analysis of randomized controlled trials
Einarson, TR
Arikian, SR
Casciano, J
Doyle, JJ
CLINICAL THERAPEUTICS, 1999, 21 (02) : 296 - 308

← 1 →